about
FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2Wnt activity defines colon cancer stem cells and is regulated by the microenvironmentThe linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death.Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients.The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients.CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma.The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features.CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinomaSingle-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.Cancer stem cells--old concepts, new insights.Label retaining cells in cancer--the dormant root of evil?Development and characteristics of preclinical experimental models for the research of rare neuroendocrine bladder cancer.Caspase-10 Negatively Regulates Caspase-8-Mediated Cell Death, Switching the Response to CD95L in Favor of NF-κB Activation and Cell Survival.A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer.Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2.TRAIL/bortezomib cotreatment is potentially hepatotoxic but induces cancer-specific apoptosis within a therapeutic window.cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes.Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.Protein profile of basal prostate epithelial progenitor cells--stage-specific embryonal antigen 4 expressing cells have enhanced regenerative potential in vivo.Martin Leverkus, 1965-2016.Defined conditions for the isolation and expansion of basal prostate progenitor cells of mouse and human origin.The influence of prostatic anatomy and neurotrophins on basal prostate epithelial progenitor cells.Survival of pancreatic cancer cells lacking KRAS function.Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection.Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations.Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme.Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment Response.Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer.Bortezomib sensitizes primary meningioma cells to TRAIL-induced apoptosis by enhancing formation of the death-inducing signaling complex.Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma.High prevalence of incidental and symptomatic venous thromboembolic events in patients with advanced pancreatic cancer under palliative chemotherapy: A retrospective cohort study.Expression and prognostic significance of cancer stem cell markers CD24 and CD44 in urothelial bladder cancer xenografts and patients undergoing radical cystectomy.Proteasome Inhibition Results in TRAIL Sensitization of Primary Keratinocytes by Removing the Resistance-Mediating Block of Effector Caspase Maturation.Apoptosis mediated by lentiviral TRAIL transfer involves transduction-dependent and -independent effectsBiochemistry and function of the DISCSuppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosisDetermination of copper speciation in highway stormwater runoff using competitive ligand exchange - Adsorptive cathodic stripping voltammetry
P50
Q28609079-EE5EFC51-60E3-49DA-8517-F639056E05E9Q29618024-7F738B1F-1B64-4DB4-BD8E-B318D7B1F74FQ33625907-6C705655-3411-4C27-AD6B-370E90534EEDQ34485182-78338C16-F93D-44DD-8F9C-1074D2187218Q35619770-358933D0-8DD5-443F-A796-6390079D5D42Q36067765-113AAE44-56E1-45A2-A3A1-02BD777026E3Q36321878-34B1DA1B-A947-46FE-86C0-7EA61E6A9C61Q36657755-B0DBD7C3-B3BA-494C-A904-A02BB849D9B2Q36869902-8E48C54D-05D9-41C4-AF3E-5140B58E09C0Q37079713-00C84E6F-AB93-4124-868D-E86EED276A36Q38102514-F1AA124D-DFE5-4C6B-B350-E2EF43D99C59Q38395812-19729A9F-BA76-4153-BE97-48033AFD3B6BQ38818426-4AD8D559-1119-4B78-9062-0371D2963894Q38856965-80396367-1A80-44A9-9C0F-2E91E314A797Q39162225-D2F260AD-D1B6-421D-B52B-D0A8F0059207Q40054867-95420EF8-F124-41E7-AD6D-4907638CEB60Q40165924-3CF1767A-177D-4268-9F5A-227FA990AE96Q40508879-42136ACE-1299-46F4-A53B-0A288069AAF2Q40563380-D2EF5F25-EA25-4163-A4C2-E18CCC98EE53Q41786997-4B621232-CB3E-4F0B-A12C-C98D09A525A1Q42328752-3F8D62EB-17BD-4A59-8E87-877CE2F19A87Q42473230-F493581A-844E-4993-9AEF-576700B1E0B5Q42483393-DF4AE23F-6F5B-45EF-B45E-874431DF6EA0Q42645888-FD76BC5B-9134-43CF-807A-9407BEB7E953Q43947256-F199C19E-89AC-4DA7-AA15-4F023067ED76Q47143099-2460658B-2305-4C97-BD7A-502BB5015E95Q47733392-1094BDF4-9FDD-4D79-8765-D3613539E74BQ47860678-FD4467F9-1ED2-4B19-996D-B63EE2CA255BQ48148098-C6A2C5CE-CD1A-493F-9E60-79AC58347B4AQ48325627-CB1FFC24-2285-4766-A93F-C20BD2A63B20Q51028257-44381D85-5EB4-4806-9DCD-E69660DCEADBQ51326493-69B65182-AB48-4BB2-B392-EE87525B5E68Q52773653-CEC487BE-DB02-4F81-A602-65DE591B711DQ53062429-1C5875D1-2DD4-4165-804C-FA3DA8CB9D06Q55521739-3FE89807-9B17-4ACF-9FCB-31D3E79E34E5Q57384572-AEE8DA75-61B7-4D9E-A5A4-F66F94655F86Q74147416-B12DE66F-4108-4AA1-BB2B-0B85CEBD8635Q80210089-96106060-1272-4F70-9B70-AE8E327322C6Q84868089-4292AEB0-E9F8-45A4-B64E-44B59FE27EE5
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin R Sprick
@nl
Martin R Sprick
@sl
Martin R. Sprick
@en
Martin R. Sprick
@es
type
label
Martin R Sprick
@nl
Martin R Sprick
@sl
Martin R. Sprick
@en
Martin R. Sprick
@es
altLabel
M Sprick
@en
M.R. Sprick
@en
MR Sprick
@en
Martin Sprick
@en
prefLabel
Martin R Sprick
@nl
Martin R Sprick
@sl
Martin R. Sprick
@en
Martin R. Sprick
@es
P1053
A-8611-2008
P106
P1153
6506957249
P2798
P31
P3829
P496
0000-0001-9691-7574